We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYN icon
4376
Dyne Therapeutics
DYN
$4.99B
$9K ﹤0.01%
449
+326
+265% +$6.45K
ECOR icon
4377
electroCore
ECOR
$82.2M
$9K ﹤0.01%
384
-26
-6% -$641
EMLC icon
4378
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.78B
$9K ﹤0.01%
274
-1,341
-83% -$42.9K
FHTX icon
4379
Foghorn Therapeutics
FHTX
$391M
$9K ﹤0.01%
+438
New +$8.39K
HOV icon
4380
Hovnanian Enterprises
HOV
$805M
$9K ﹤0.01%
275
-336
-55% -$12.1K
IGOV icon
4381
iShares International Treasury Bond ETF
IGOV
$1.53B
$9K ﹤0.01%
+168
New +$9.09K
ING icon
4382
ING
ING
$101B
$9K ﹤0.01%
958
-305
-24% -$2.62K
IRIX icon
4383
IRIDEX
IRIX
$15.5M
$9K ﹤0.01%
+3,704
New +$6.98K
JGH icon
4384
Nuveen Global High Income Fund
JGH
$356M
$9K ﹤0.01%
+562
New +$8.09K
KNTK icon
4385
Kinetik
KNTK
$4.11B
$9K ﹤0.01%
400
-5,348
-93% -$78.2K
LEU icon
4386
Centrus Energy
LEU
$3.77B
$9K ﹤0.01%
400
-1,864
-82% -$26K
MIND icon
4387
MIND Technology
MIND
$43.9M
$9K ﹤0.01%
396
+305
+335% +$6.8K
MJ icon
4388
Amplify Alternative Harvest ETF
MJ
$109M
$9K ﹤0.01%
52
MNPR icon
4389
Monopar Therapeutics
MNPR
$767M
$9K ﹤0.01%
281
-659
-70% -$17K
NRP icon
4390
Natural Resource Partners
NRP
$1.37B
$9K ﹤0.01%
662
+562
+562% +$7.62K
NTIC icon
4391
Northern Technologies International Corp
NTIC
$76.2M
$9K ﹤0.01%
843
+750
+806% +$6.85K
OCC icon
4392
Optical Cable Corp
OCC
$141M
$9K ﹤0.01%
3,649
+2,301
+171% +$6.79K
OTLK icon
4393
Outlook Therapeutics
OTLK
$211M
$9K ﹤0.01%
+338
New +$7.06K
PCSA icon
4394
Processa Pharmaceuticals
PCSA
$8.82M
$9K ﹤0.01%
+3
New +$8.33K
PHI icon
4395
PLDT
PHI
$4.23B
$9K ﹤0.01%
331
-4,453
-93% -$124K
PSO icon
4396
Pearson
PSO
$9.72B
$9K ﹤0.01%
905
-7,774
-90% -$62.3K
PULM icon
4397
Pulmatrix
PULM
$5.84M
$9K ﹤0.01%
362
-94
-21% -$2.24K
SANW
4398
DELISTED
S&W Seed Co
SANW
$9K ﹤0.01%
176
+41
+30% +$1.97K
SID icon
4399
Companhia Siderúrgica Nacional
SID
$1.15B
$9K ﹤0.01%
1,500
-1,644
-52% -$7.01K
FIRY
4400
Firy Inc
FIRY
$160M
$9K ﹤0.01%
23
-162
-88% -$48.1K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.